SCHEMBL6161763

SCHEMBL6161763

CC(C)c1ccccc1OP(Oc1ccccc1)Oc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
MEN1 O00255 2/20 0.42
CYP1A2 P05177 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
RECQL P46063 1/20 0.42
GABRA1 P14867 2/20 0.36
GABRB2 P47870 2/20 0.36
P2RX3 P56373 1/20 0.36
P2RX2 Q9UBL9 1/20 0.36
HTR2A P28223 1/20 0.36
SLC6A4 P31645 1/20 0.36
NISCH Q9Y2I1 2/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
LMNA P02545 4/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11117448 1.00 KMT2A (0.42) KMT2AL3MBTL1MEN1CYP1A2CYP3A4
SCHEMBL29636737 0.90 GABRA1 (0.43) KMT2AL3MBTL1MEN1CYP1A2CYP3A4
SCHEMBL2861909 0.90 GABRA1 (0.43) KMT2AL3MBTL1MEN1CYP1A2CYP3A4
SCHEMBL2603176 0.83 KMT2A (0.41) KMT2AL3MBTL1MEN1CYP1A2CYP3A4
SCHEMBL17528777 0.80 LTA4H (0.41) KMT2ASLC6A4LMNAALDH1A1CA1
SCHEMBL13839469 0.77 P2RX3 (0.37) KMT2AL3MBTL1MEN1CYP1A2CYP3A4
SCHEMBL13839494 0.77 ELANE (0.44) KMT2AL3MBTL1MEN1CYP1A2CYP2C19
SCHEMBL6682183 0.76 SLC6A4 (0.51) KMT2AL3MBTL1MEN1CYP1A2CYP3A4
SCHEMBL4900277 0.76 TYR (0.41) KMT2AL3MBTL1MEN1CYP2C9HTR2A
SCHEMBL13839664 0.75 ALDH1A1 (0.41) KMT2AL3MBTL1MEN1CYP3A4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1312598-B1 Process for producing aldehyde MITSUBISHI CHEM CORP (JP) 2005-02-16 EP disclosed
EP-1008581-B1 Process for producing aldehyde MITSUBISHI CHEM CORP (JP) 2004-04-21 EP disclosed
US-6610891-B1 Reduces degradation or decomposition of catalyst MITSUBISHI CHEMICAL CORPORATION (JP) 2003-08-26 US disclosed
US-6583324-B2 By hydroformylation with rhodium complex catalyst containing an organic phosphite ligand; preventing catalyst poisoning by having the aldehyde remain in the catalyst solution in the separation step MITSUBISHI CHEMICAL CORPORATION (JP) 2003-06-24 US disclosed
EP-1312598-A1 Process for producing aldehyde MITSUBISHI CHEMICAL CORPORATION (JP) 2003-05-21 EP disclosed
US-20020049355-A1 Process for producing aldehyde MITSUBISHI CHEMICAL CORPORATION (JP) 2002-04-25 US disclosed
US-6291717-B1 REACTING OLEFINIC COMPOUND WITH CARBON MONOXIDE AND HYDROGEN IN THE PRESENCE OF A RHODIUM COMPLEX CATALYST COMPRISING RHODIUM AND ORGANIC PHOSPHITE IN REACTION ZONE; SEPARATING CATALYST AND ALDEHYDE; RECYCLING CATALYST SOLUTION MITSUBISHI CHEMICAL CORPORATION (JP) 2001-09-18 US disclosed
US-5672766-A REACTING OLEFIN WITH CARBON MONOXIDE AND HYDROGEN IN THE PRESENCE OF A RHODIUM COMPLEX CATALYST MITSUBISHI CHEMICAL CORPORATION (JP) 1997-09-30 US disclosed
US-5648554-A GROUP 8 METAL PHOSPHITE COMPLEX CATALYST MITSUBISHI CHEMICAL CORPORATION (JP) 1997-07-15 US disclosed
US-4469644-A CATALYTIC OXIDATION OF CORRESPONDING PHOISPHITE BORG-WARNER CHEMICALS, INC. (US) 1984-09-04 US disclosed
US-4202843-A Process for the production of organic phosphates by nitric acid oxidation of organic phosphites TENNECO CHEMICALS, INC. (US) 1980-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020049355-A1 Process for producing aldehyde ALDH2, OGDH, HAO2 KMT2A 2019/4885L3MBTL1 4087/4885MEN1 3237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.